Co Trimazine

Main information

  • Trade name:
  • Co Trimazine Tablets 480 mg
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Co Trimazine Tablets 480 mg
    United Kingdom
  • Language:
  • English

Other information

Status

  • Source:
  • VMD - Veterinary Medicines Directorate
  • Authorization status:
  • Expired
  • Authorization number:
  • 41687/4004
  • Last update:
  • 21-12-2016

Summary of Product characteristics

Revised: October 2012

AN: 00752/2012

SUMMARY OF PRODUCT CHARACTERISTICS

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Co Trimazine Tablets 480 mg

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each tablet contains

Active Substance(s): mg :

Trimethoprim   80 

Sulfadiazine  400 

Excipients:

For a full list of excipients, see section 6.1

3. PHARMACEUTICAL FORM

Tablet.

A circular, uncoated, white tablet scored on one face.

4. CLINICAL PARTICULARS

4.1 Target species

Dogs

4.2 Indications for use, specifying the target species

When susceptible organisms are present the Tablets may be effective in treating

the   following   conditions:   alimentary   tract   infections,   respiratory   and   urogenital

infections, skin and wound infections and eye and ear infections.

4.3 Contraindications

Co-trimazine Tablets 480 mg are not suitable for use in cats.

4.4 Special Warnings for each target species

No special warnings.

Page 1 of 4

Revised: October 2012

AN: 00752/2012

4.5 Special precautions for use

Special precautions for use in animals

Use of the product should be based on susceptibility testing of bacteria

isolated from the animal. If this is not possible, therapy should be based

on   local   (regional,   farm   level)   epidemiological   information   about

susceptibility of the target bacteria.

Special precautions to be taken by the person administering the veterinary

medicinal product to animals

Take care to avoid skin contact. 

Wash hands after use.

Sulphonamides   may   cause   hypersensitivity   (allergy)   following   injection,

inhalation,   ingestion   or   skin   contact.   Hypersensitivity   to   sulphonamides

may lead to cross reaction with other antibiotics. Allergic reactions to these

substances may occasionally be serious.

1.   Do   not   handle   this   product   if   you   know   you   are   sensitive   to

sulphonamides.

2. If you develop symptoms following exposure such as skin rash, you

should seek medical advice and show the doctor this warning.

4.6 Adverse reactions (frequency and seriousness)

A low incidence of polyarthropathy and Keratoconjunctivitis Sicca (Dry Eye) has

been reported in dogs following oral administration of potentiated sulfonamides.

If either of these conditions occur, it is recommended that medication is stopped

and that future treatment is avoided.

Sulfonamide sensitivity is rare in companion animals but should be considered in

cases of unexpected responses to treatment.

4.7 Use during pregnancy, lactation or lay

Can be safely administered during pregnancy and lactation.

4.8 Interaction with other medicinal products and other forms of interaction

No known interactions.

Page 2 of 4

Revised: October 2012

AN: 00752/2012

4.9 Amounts to be administered and administration route

The daily dose is one tablet per 16 kg bodyweight administered orally, providing

30 mg of combined active ingredients per kg bodyweight. Treatment should be

continued for up to five days or until 2 days after symptoms have subsided.

To ensure a correct dosage, bodyweight should be determined as accurately as 

possible to avoid underdosing.

4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary

No treatment specified.

4.11 Withdrawal period

Not applicable

5. PHARMACOLOGICAL PROPERTIES

Pharmacotherapeutic group:  Sulfonamides

ATC Vet Code:  QJ01EW10

5.1 Pharmacodynamic properties

Sulfadiazine (SDZ) inhibits the incorporation of para-aminobenzoic acid into folic

acid and trimethoprim (TMP) inhibits the enzyme dihydrofolate reductase (DHFR)

which converts dihydrofolic acid into tetrahydrofolic acid.  (TMP) and (SDZ) act

together synergistically with a double-blockade mode of action.  The combination

is bactericidal   inhibiting sequential steps in the synthesis of purines which are

required for DNA synthesis.   TMP-SDZ combinations have a broad bactericidal

action against   many   gram-positive  and  gram-negative  aerobic  bacteria  and  a

large proportion of anaerobic bacteria.

6. PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Microcrystalline Cellulose,

Povidone (K12),

Lactose monohydrate,

Sodium Starch Glycollate, Type A,

Magnesium stearate.

6.2 Incompatibilities

Not applicable

Page 3 of 4

Revised: October 2012

AN: 00752/2012

6.3 Shelf life

Shelf life of the veterinary medicinal product as packaged for sale: 2 years.

6.4 Special precautions for storage

Do not store above 25oC.

Store in a dry place.

Protect from light.

6.5 Nature and composition of immediate packaging

White opaque  polypropylene tub with a  white opaque polyethylene cap (push fit)

(tamper evident) containing either 100 or 500 tablets.

Not all pack sizes may be marketed.

6.6 Special   precautions   for   the   disposal   of   unused   veterinary   medicinal

product or waste materials derived from the use of such products

Any unused product or waste material should be disposed of in accordance with

national requirements.

7. MARKETING AUTHORISATION HOLDER

Listow Limited

9 Belgrave Square

London

SW1X 8PH

8. MARKETING AUTHORISATION NUMBER(S)

Vm  41687/4004

9. DATE OF FIRST AUTHORISATION

Date: 28 August 1997 

10. DATE OF REVISION OF THE TEXT

Date: October 2012

Page 4 of 4

20-4-2018

Shenzhen Wismec Electronics Co., Ltd. recalls Wismec Exo Skeleton Vaporizers

Shenzhen Wismec Electronics Co., Ltd. recalls Wismec Exo Skeleton Vaporizers

The recalled products have a firmware issue that can lead to a charging failure causing overcurrent to be supplied to the batteries. This results in overheating, posing fire and burn hazards.

Health Canada

9-4-2018

Kohler Co. recalls Automatic Transfer Switch

Kohler Co. recalls Automatic Transfer Switch

The cable and screw terminal joint may relax creating a potential risk of heating and possible failure of the connection.

Health Canada

18-4-2018

SILVER SULFADIAZENE (Silver Sulfadiazine) Cream [Unit Dose Services]

SILVER SULFADIAZENE (Silver Sulfadiazine) Cream [Unit Dose Services]

Updated Date: Apr 18, 2018 EST

US - DailyMed

13-4-2018

LUBRICANT EYE (Carboxymethylcellulose Sodium) Solution/ Drops [The Kroger Co.]

LUBRICANT EYE (Carboxymethylcellulose Sodium) Solution/ Drops [The Kroger Co.]

Updated Date: Apr 13, 2018 EST

US - DailyMed

13-4-2018

ANTIMICROBIAL (Chloroxylenol) Soap [Sky Systems Co., Inc]

ANTIMICROBIAL (Chloroxylenol) Soap [Sky Systems Co., Inc]

Updated Date: Apr 13, 2018 EST

US - DailyMed

13-4-2018

DR FROG TOCOVITA ENERGY (Dimethicone) Cream [Charmzone Co Ltd]

DR FROG TOCOVITA ENERGY (Dimethicone) Cream [Charmzone Co Ltd]

Updated Date: Apr 13, 2018 EST

US - DailyMed

13-4-2018

DR FROG WATER FULL CHARGE (Dimethicone) Cream [Charmzone Co Ltd]

DR FROG WATER FULL CHARGE (Dimethicone) Cream [Charmzone Co Ltd]

Updated Date: Apr 13, 2018 EST

US - DailyMed

13-4-2018

ANTISEPTIC (Chloroxylenol) Soap [Sky Systems Co., Inc]

ANTISEPTIC (Chloroxylenol) Soap [Sky Systems Co., Inc]

Updated Date: Apr 13, 2018 EST

US - DailyMed

13-4-2018

XOUL INTENSIVE CELL RE-VITAL AMPOULE (Glycerin) Gel [PICOSTECH Co.,Ltd.]

XOUL INTENSIVE CELL RE-VITAL AMPOULE (Glycerin) Gel [PICOSTECH Co.,Ltd.]

Updated Date: Apr 13, 2018 EST

US - DailyMed

13-4-2018

XOUL INTENSIVE CELL RE-VITAL (Glycerin) Cream [PICOSTECH Co.,Ltd.]

XOUL INTENSIVE CELL RE-VITAL (Glycerin) Cream [PICOSTECH Co.,Ltd.]

Updated Date: Apr 13, 2018 EST

US - DailyMed

13-4-2018

XOUL INTENSIVE CELL RECOVERY SERUM (Glycerin) Gel [PICOSTECH Co.,Ltd.]

XOUL INTENSIVE CELL RECOVERY SERUM (Glycerin) Gel [PICOSTECH Co.,Ltd.]

Updated Date: Apr 13, 2018 EST

US - DailyMed

13-4-2018

DR FROG PP SUN BLOCK (Titanium Dioxide, Zinc Oxide) Cream [Charmzone Co Ltd]

DR FROG PP SUN BLOCK (Titanium Dioxide, Zinc Oxide) Cream [Charmzone Co Ltd]

Updated Date: Apr 13, 2018 EST

US - DailyMed

13-4-2018

LORATADINE ODT (Loratadine) Tablet, Orally Disintegrating [WALGREEN CO.]

LORATADINE ODT (Loratadine) Tablet, Orally Disintegrating [WALGREEN CO.]

Updated Date: Apr 13, 2018 EST

US - DailyMed

13-4-2018

ORAL ANTIVAVITY (Sodium Fluoride) Mouthwash [Kroger Co]

ORAL ANTIVAVITY (Sodium Fluoride) Mouthwash [Kroger Co]

Updated Date: Apr 13, 2018 EST

US - DailyMed

12-4-2018

HAND SANITIZER (Ethyl Alcohol) Gel [The Kroger Co]

HAND SANITIZER (Ethyl Alcohol) Gel [The Kroger Co]

Updated Date: Apr 12, 2018 EST

US - DailyMed

12-4-2018

SILVER SULFADIAZINE Cream [Unit Dose Services]

SILVER SULFADIAZINE Cream [Unit Dose Services]

Updated Date: Apr 12, 2018 EST

US - DailyMed

11-4-2018

News and press releases:  Redistribution of UK’s portfolio of centrally authorised products

News and press releases: Redistribution of UK’s portfolio of centrally authorised products

Assignment of new rapporteurs and co-rapporteurs completed

Europe - EMA - European Medicines Agency

11-4-2018

SULFAMETHOXAZOLE AND TRIMETHOPRIM Tablet [Rising Health, LLC]

SULFAMETHOXAZOLE AND TRIMETHOPRIM Tablet [Rising Health, LLC]

Updated Date: Apr 11, 2018 EST

US - DailyMed

10-4-2018

PEPPLUS WRINKLE (Dimethicone) Cream [Picobio Co., Ltd]

PEPPLUS WRINKLE (Dimethicone) Cream [Picobio Co., Ltd]

Updated Date: Apr 10, 2018 EST

US - DailyMed

10-4-2018

ZOLPIDEM TARTRATE Tablet [H. J. Harkins Co., Inc.]

ZOLPIDEM TARTRATE Tablet [H. J. Harkins Co., Inc.]

Updated Date: Apr 10, 2018 EST

US - DailyMed

10-4-2018

PEPPLUS WRINKLE EYE (Adenosine) Cream [Picobio Co., Ltd]

PEPPLUS WRINKLE EYE (Adenosine) Cream [Picobio Co., Ltd]

Updated Date: Apr 10, 2018 EST

US - DailyMed

6-4-2018

MEDI PEEL CENTELLA MEZZO (Niacinamide, Adenosine) Cream [Skinidea Co.,Ltd.]

MEDI PEEL CENTELLA MEZZO (Niacinamide, Adenosine) Cream [Skinidea Co.,Ltd.]

Updated Date: Apr 6, 2018 EST

US - DailyMed

6-4-2018

DIAPER RASH CREAM (Zinc Oxide) Ointment [Private Label Select Ltd CO]

DIAPER RASH CREAM (Zinc Oxide) Ointment [Private Label Select Ltd CO]

Updated Date: Apr 6, 2018 EST

US - DailyMed

6-4-2018

MEDI PEEL TRANEX MELA X (Niacinamide, Adenosine) Cream [Skinidea Co.,Ltd.]

MEDI PEEL TRANEX MELA X (Niacinamide, Adenosine) Cream [Skinidea Co.,Ltd.]

Updated Date: Apr 6, 2018 EST

US - DailyMed

5-4-2018

PEPPLUS SPECIAL SKIN CARE LIFTING PROGRAM (Glycerin) Cream [Picobio Co., Ltd]

PEPPLUS SPECIAL SKIN CARE LIFTING PROGRAM (Glycerin) Cream [Picobio Co., Ltd]

Updated Date: Apr 5, 2018 EST

US - DailyMed

5-4-2018

CALAMINE (Calamine, Pramoxind Hcl) Lotion [Walgreen CO]

CALAMINE (Calamine, Pramoxind Hcl) Lotion [Walgreen CO]

Updated Date: Apr 5, 2018 EST

US - DailyMed

5-4-2018

CALAMINE (Ferric Oxide Red) Lotion [Walgreen Co.]

CALAMINE (Ferric Oxide Red) Lotion [Walgreen Co.]

Updated Date: Apr 5, 2018 EST

US - DailyMed

4-4-2018

CLEAR ANTI-ITCH (Pramoxine Hcl, Zinc Acetate) Lotion [Walgreen CO]

CLEAR ANTI-ITCH (Pramoxine Hcl, Zinc Acetate) Lotion [Walgreen CO]

Updated Date: Apr 4, 2018 EST

US - DailyMed

4-4-2018

PEPPLUS LIFTING ESSENCE (Dimethicone) Cream [Picobio Co., Ltd]

PEPPLUS LIFTING ESSENCE (Dimethicone) Cream [Picobio Co., Ltd]

Updated Date: Apr 4, 2018 EST

US - DailyMed

4-4-2018

EASYDEW DW EGF DERMA NEEDLE 3000 SHOT (Nepidermin) Solution [DN Company Co.,Ltd.]

EASYDEW DW EGF DERMA NEEDLE 3000 SHOT (Nepidermin) Solution [DN Company Co.,Ltd.]

Updated Date: Apr 4, 2018 EST

US - DailyMed

3-4-2018

EU/3/12/1080 (AbbVie Deutschland GmbH and Co. KG)

EU/3/12/1080 (AbbVie Deutschland GmbH and Co. KG)

EU/3/12/1080 (Active substance: 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide) - Transfer of orphan designation - Commission Decision (2018)2056 of Tue, 03 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/124/12/T/01

Europe -DG Health and Food Safety

3-4-2018

NYSTATIN Cream [E. Fougera Co. A Division Of Fougera Pharmaceuticals Inc.]

NYSTATIN Cream [E. Fougera Co. A Division Of Fougera Pharmaceuticals Inc.]

Updated Date: Apr 3, 2018 EST

US - DailyMed

2-4-2018

WHITE LABS (Hydrogen Peroxide) Liquid [BIOSTECH CO., LTD.]

WHITE LABS (Hydrogen Peroxide) Liquid [BIOSTECH CO., LTD.]

Updated Date: Apr 2, 2018 EST

US - DailyMed